Overview

Combined Triple Procedure in Retinal Vein Occlusion (RVO)

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with retinal vein occlusion (RVO).
Phase:
Phase 3
Details
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Treatments:
Bevacizumab
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide